• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

向复杂病变部位输送生物可吸收血管支架。

Delivery of a bioresorbable vascular scaffold to complex lesions.

作者信息

Meincke Felix, Kuck Karl-Heinz, Bergmann Martin W

机构信息

Department of Cardiology, Asklepios Klinik St. Georg, Lohmuehlenstrasse 5, Hamburg, Germany.

出版信息

Catheter Cardiovasc Interv. 2014 Nov 1;84(5):774-8. doi: 10.1002/ccd.25105. Epub 2014 Jul 30.

DOI:10.1002/ccd.25105
PMID:23907893
Abstract

The use of bioresorbable vascular scaffolds (BVS) in percutaneous coronary interventions holds great promise and the Absorb® BVS is increasingly used in clinical practice outside of controlled studies. However, questions have been raised concerning the delivery of the scaffold to complex lesions. We describe a case of successful delivery and implantation of two overlapping Absorb® BVS to a complex lesion in the left anterior descending artery. The crossing of the lesions was uneventful and after implantation a good acute result could be documented. A follow-up angiogram after 3 months proofed a stable midterm result. We thereby demonstrate the feasibility of delivering Absorb® BVS to more complex lesions than practiced so far in the setting of clinical trials.

摘要

生物可吸收血管支架(BVS)在经皮冠状动脉介入治疗中的应用前景广阔,在对照研究之外,Absorb® BVS越来越多地应用于临床实践。然而,关于该支架在复杂病变中的输送问题已引发关注。我们描述了1例成功将2个重叠的Absorb® BVS输送并植入左前降支复杂病变的病例。病变部位的通过过程顺利,植入后可记录到良好的急性结果。3个月后的随访血管造影显示中期结果稳定。我们由此证明了在临床试验环境中,将Absorb® BVS输送至比目前实践中更复杂病变的可行性。

相似文献

1
Delivery of a bioresorbable vascular scaffold to complex lesions.向复杂病变部位输送生物可吸收血管支架。
Catheter Cardiovasc Interv. 2014 Nov 1;84(5):774-8. doi: 10.1002/ccd.25105. Epub 2014 Jul 30.
2
Very late bioresorbable vascular scaffold thrombosis due to late device recoil.由于晚期器械回缩导致的极晚期生物可吸收血管支架血栓形成。
Int J Cardiol. 2015;189:132-3. doi: 10.1016/j.ijcard.2015.04.018. Epub 2015 Apr 3.
3
Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.在 ABSORB-EXTEND 单臂试验中,435 例患者接受依维莫司洗脱生物可吸收血管支架治疗后小分支闭塞的发生率及短期临床结局:与 SPIRIT 试验 I 和 II 中依维莫司洗脱金属支架的比较。
JACC Cardiovasc Interv. 2013 Mar;6(3):247-57. doi: 10.1016/j.jcin.2012.10.013.
4
Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up.生物可吸收血管支架和金属平台支架置入后 1 年时管腔-动脉壁的血管造影几何变化。
JACC Cardiovasc Interv. 2011 Jul;4(7):789-99. doi: 10.1016/j.jcin.2011.04.009.
5
The ABSORB bioresorbable vascular scaffold: A novel, fully resorbable drug-eluting stent: Current concepts and overview of clinical evidence.ABSORB生物可吸收血管支架:一种新型的、完全可吸收的药物洗脱支架:当前概念及临床证据概述
Catheter Cardiovasc Interv. 2015 Oct;86(4):664-77. doi: 10.1002/ccd.26172.
6
Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.真实世界人群中ABSORB生物可吸收血管支架与依维莫司洗脱支架植入早期临床结局的比较
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):E10-5. doi: 10.1002/ccd.25569. Epub 2014 Jul 16.
7
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).植入可吸收依维莫司洗脱完全生物可吸收血管支架后急性支架断裂和晚期结构不连续性的发生率和影像学结果:ABSORB 队列 B 试验的光学相干断层成像评估(生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变患者的临床评价)。
JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016.
8
Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent.比较生物可吸收依维莫司洗脱冠状动脉支架(修订版 1.0 和 1.1)与金属依维莫司洗脱支架的体内急性支架回缩。
Catheter Cardiovasc Interv. 2011 Jul 1;78(1):3-12. doi: 10.1002/ccd.22864. Epub 2011 Mar 16.
9
A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者植入生物可吸收血管支架后12个月的血管造影和光学相干断层扫描随访
Catheter Cardiovasc Interv. 2015 Oct;86(4):E180-9. doi: 10.1002/ccd.26006. Epub 2015 May 25.
10
Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: The importance of vessel sizing and scaffold thickness.
Catheter Cardiovasc Interv. 2015 Oct;86(4):686-91. doi: 10.1002/ccd.26055. Epub 2015 Jun 29.

引用本文的文献

1
Cutting balloon use may ease the optimal apposition of bioresorbable vascular scaffold in in-stent stenosis.使用切割球囊可能有助于生物可吸收血管支架在支架内狭窄中实现最佳贴壁。
Postepy Kardiol Interwencyjnej. 2015;11(1):64-6. doi: 10.5114/pwki.2015.49190. Epub 2015 Mar 6.